Novel agents in the treatment of lung cancer: Fourth Cambridge conference

Clinical Cancer Research

Volumn 13, Issue 15, 2007, Pages

  Lynch, Thomas J ^a   Bonomi, Philip D ^c   Butts, Charles ^d   Davies, Angela M ^e   Engelman, Jeffrey ^a   Govindan, Ramaswamy ^f   Herbst, Roy S ^g   Heymach, John V ^g   Johnson, Bruce E ^b   Martins, Renato G ^h   Perez Soler, Roman ⁱ   Riely, Gregory J ^j   Sandler, Alan B ^k   Sequist, Lecia V ^a   Socinski, Mark A ^l   Wong, Kwok Kin ^b   Hart, Carol S ^m  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d CROSS CANCER INSTITUTE   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ MONTEFIORE MEDICAL CENTER   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^k VANDERBILT INGRAM CANCER CENTER   (United States)

^l UNIVERSITY OF NORTH CAROLINA   (United States)

^m InforMEDical   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUORO 2 METHYL 5 INDOLYLOXY) 6 METHOXY 7 [3 (1 PYRROLIDINYL)PROPOXY]QUINAZOLINE; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BORTEZOMIB; CANFOSFAMIDE; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; EVEROLIMUS; HKI 272; IMATINIB; K RAS PROTEIN; LBLP 25; MATUZUMAB; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MONOCLONAL ANTIBODY; PACLITAXEL; PACLITAXEL POLIGLUMEX; PANITUMUMAB; PEMETREXED; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; SORAFENIB; STIMUVAX; SUNITINIB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANDETANIB; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

BASIC RESEARCH; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESEARCH; CANCER RESISTANCE; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; RASH; UNITED STATES;

ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; HUMANS; LUNG NEOPLASMS;

EID: 34547652647     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0716     Document Type: Conference Paper

References (0)